Sara Grootwassink Lewis
Sara Grootwassink Lewis's purchase track record
How the stock did after each of Sara Grootwassink Lewis's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/17/2025 | WY | $106K | -0.4% | +4.3% | +10.4% |
| 8/11/2025 | WY | $101K | -9.6% | +7.3% | +9.3% |
| 4/28/2025 | DOC | $106K | -1.1% | +11.1% | +24.3% |
| 3/4/2024 | DOC | $301K | +19.2% | +35.7% | +7.8% |
| 5/12/2023 | FCX | $140K | +18.8% | -3.0% | +7.1% |
| 3/15/2023 | DOC | $86K | -2.5% | -5.1% | +14.8% |
| 8/3/2022 | FCX | $86K | +8.6% | +57.5% | -0.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend. Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BofA Upgrades Weyerhaeuser to Buy, Cites Lumber Challenges. Bank of America upgraded Weyerhaeuser to Buy but lowered its price target to $25. The firm noted weak demand in the lumber market, a concern also affecting Louisiana-Pacific. This move comes as paper and packaging stocks face pressure from input cost inflation and rising wholesale prices.
Transaction History
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| DOC | ▲ Buy | Grant | 9,744 | $0 | 5/6/2026 | View on chart |
| WY | ▲ Buy | Open Market | 4,500 | $106K | 12/17/2025 | View on chart |
| WY | ▲ Buy | Open Market | 4,000 | $101K | 8/11/2025 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| DOC | ▲ Buy | Open Market | 6,000 | $106K | 4/28/2025 | View on chart |
| DOC | ▲ Buy | Grant | 10,657 | $0 | 4/25/2025 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| DOC | ▲ Buy | Grant | 9,575 | $0 | 4/26/2024 | View on chart |
| DOC | ▲ Buy | Open Market | 18,000 | $301K | 3/4/2024 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| FCX | ▲ Buy | Open Market | 4,000 | $140K | 5/12/2023 | View on chart |
| DOC | ▲ Buy | Grant | 8,193 | $0 | 4/28/2023 | View on chart |
| DOC | ▲ Buy | Open Market | 4,000 | $86K | 3/15/2023 | View on chart |
| FCX | ▲ Buy | Open Market | 3,000 | $86K | 8/3/2022 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| WY | ▼ Sell | Tax Withholding | 80 | $3K | 5/14/2022 | View on chart |
| DOC | ▲ Buy | Grant | 5,258 | $0 | 4/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.